<code id='38C5AA53D8'></code><style id='38C5AA53D8'></style>
    • <acronym id='38C5AA53D8'></acronym>
      <center id='38C5AA53D8'><center id='38C5AA53D8'><tfoot id='38C5AA53D8'></tfoot></center><abbr id='38C5AA53D8'><dir id='38C5AA53D8'><tfoot id='38C5AA53D8'></tfoot><noframes id='38C5AA53D8'>

    • <optgroup id='38C5AA53D8'><strike id='38C5AA53D8'><sup id='38C5AA53D8'></sup></strike><code id='38C5AA53D8'></code></optgroup>
        1. <b id='38C5AA53D8'><label id='38C5AA53D8'><select id='38C5AA53D8'><dt id='38C5AA53D8'><span id='38C5AA53D8'></span></dt></select></label></b><u id='38C5AA53D8'></u>
          <i id='38C5AA53D8'><strike id='38C5AA53D8'><tt id='38C5AA53D8'><pre id='38C5AA53D8'></pre></tt></strike></i>

          leisure time

          leisure time

          author:entertainment    Page View:9864
          Cosmetics
          Alberto Pellaschiar/AP

          WASHINGTON — For those already felled by fumes from the Brazilian Blowout, it might be small consolation, but lawmakers are pushing ahead with a campaign for better oversight of the beauty business.

          Despite its booming growth, the cosmetics industry in the US has been virtually unregulated. The Food, Drug, and Cosmetic Act, adopted in 1938, essentially allowed personal care product companies to self-police.

          advertisement

          But rising public concern over bad reactions to makeup, hair dyes, and fragrances, as well as evidence of long-term health risks from some of their chemical contents, has led lawmakers to try to toughen the regulatory framework for the $60 billion enhancement industry.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          Johnson & Johnson sued for allegedly overpaying for workers' drugs
          Johnson & Johnson sued for allegedly overpaying for workers' drugs

          ChrisO'Meara/APJohnson&Johnsonfacesaconsequentialnewclassactionlawsuit—notinitsroleasamanuf

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Unique patient identifier: Experts argue the benefits, pitfalls

          Therehasbeenlong-standingdebateintheUSoverwhethertoimplementauniquepatientidentifiersystem.EvanVucci